Document:

EXHIBIT
      10.2

    
      

CAPITAL
      CONTRIBUTION AGREEMENT

     

     

    THIS
      CAPITAL CONTRIBUTION AGREEMENT (the
      “Agreement”) is made and entered into on June 9, 2005 by and among IQ
      MEDICAL CORP.,
      a
      Colorado corporation (“IQMC”), and OSMOTEX
      USA, INC., a
      Florida
      corporation (“Osmotex”). IQMC and Osmotex are collectively referred to herein as
      the “Parties”.

    

    WHEREAS,
      Osmotex
      owns certain rights to the licensing of certain technology (the “Licensing
      Rights”); and 

    

    WHEREAS,
      Osmotex
      wishes to contribute the Licensing Rights to IQMC as a capital contribution
      in
      exchange for the issuance of common stock by IQMC as contemplated in this
      Agreement; and

    

    WHEREAS,
      the
      Parties wish to document their agreement regarding this transaction in this
      Agreement.

    

    NOW,
      THEREFORE,
      in
      consideration of the mutual terms, conditions and other agreements set forth
      herein, and for other valuable consideration, the receipt and adequacy of which
      are hereby conclusively acknowledged, the Parties hereto, intending to be
      legally bound, hereby agree as follows:

    

    ARTICLE
      1

    

    CAPITAL
      CONTRIBUTION; ISSUANCE OF SHARES

    

    1.1     CAPITAL
      CONTRIBUTION.
      Upon
      the
      terms and subject to the conditions set forth in this Agreement, Osmotex hereby
      contributes (the “Capital Contribution”) the Licensing Rights to IQMC as a
      contribution to the capital of IQMC. IQMC hereby accepts this Capital
      Contribution. In exchange for this Capital Contribution, IQMC hereby issues
      42,670,000 shares (the “Shares”) of its $0.0001 par value per share common stock
      to Osmotex.

    

    1.2     TIME
      AND PLACE OF CLOSING.
      The
      closing of the transactions contemplated hereby (the “Closing”) will take place
      on the date hereof, or at such other time as the Parties, acting through their
      authorized officers, may mutually agree. The Closing shall be held at such
      location as may be mutually agreed upon by the Parties or may be conducted
      by
      mail, email or facsimile as may be mutually agreed upon by the
      Parties.

    ARTICLE
      2

    

    REPRESENTATIONS
      AND WARRANTIES OF IQMC

    

    IQMC
      hereby represents and warrants to Osmotex as follows:

    
      
        
        

      

      
        -1-

        
          

        

      

      
        
        

      

    

    

    2.1     ORGANIZATION,
      STANDING, AND POWER.
      IQMC is
      a corporation duly organized, validly existing, and in good standing under
      the
      Laws of the State of Colorado, and has the corporate power and authority to
      carry on its business as now conducted.

    

    2.2     AUTHORITY
      OF IQMC; NO BREACH BY AGREEMENT.

    

    (a)     IQMC
      has the corporate power and authority necessary to execute, deliver, and perform
      its obligations under this Agreement and to consummate the transactions
      contemplated hereby. The execution, delivery, and performance of this Agreement
      and the consummation of the transactions contemplated herein have been duly
      and
      validly authorized by all necessary corporate and shareholder action in respect
      thereof on the part of IQMC. This Agreement represents a legal, valid, and
      binding obligation of IQMC, enforceable against IQMC in accordance with its
      terms (except in all cases as such enforceability may be limited by applicable
      bankruptcy, insolvency, reorganization, receivership, conservatorship,
      moratorium, or similar Laws affecting the enforcement of creditors’ rights
      generally and except that the availability of the equitable remedy of specific
      performance or injunctive relief is subject to the discretion of the court
      before which any proceeding may be brought).

    

    (b)     Neither
      the execution and delivery of this Agreement by IQMC, nor the consummation
      by
      IQMC of the transactions contemplated hereby, nor compliance by IQMC with any
      of
      the provisions hereof, will (i) conflict with or result in a breach of any
      provision of IQMC’s Articles of Incorporation or Bylaws, or (ii) constitute or
      result in a default under, or require any consent pursuant to, any Contract
      or
      Permit of IQMC. 

    

    (c)     No
      notice to, filing with, or Consent of, any public body or authority is necessary
      for the consummation by IQMC of transactions contemplated in this
      Agreement.

    

    2.3     CAPITAL
      STOCK.

    

    (a)     The
      authorized capital stock of IQMC (the “IQMC Capital Stock”) consists of
      (i)  300,000,000 shares of IQMC Common Stock, of which 38,860,877 shares
      are issued and outstanding as of the date of this Agreement and (ii) 25,000,000
      shares of preferred stock, of which no shares are issued or outstanding. All
      of
      the issued and outstanding shares of IQMC Common Stock are duly and validly
      issued and outstanding and are fully paid and nonassessable. None of the
      outstanding shares of IQMC Capital Stock has been issued in violation of any
      preemptive rights of the current or past shareholders of IQMC. When all of
      the
      transactions contemplated by this Agreement and Section 1.3 of the Financing
      Agreement (as defined herein) have been consummated, Osmotex will own a total
      of
      85.0% of the outstanding IQMC Capital Stock on a fully diluted basis (including,
      without limitation, all options, warrants and other rights to purchase IQMC
      Capital Stock).

    
      
        
        

      

      
        -2-

        
          

        

      

      
        
        

      

    

    

    (b)     No
      agreements or undertakings of any kind exist which grant or would grant any
      party the right to obtain ownership of any IQMC Capital Stock.

    

    (c)     Schedule
      2.3(c)
      contains
      a true and complete list of all of the current holders of IQMC Capital Stock
      along with the amounts owned by each such party.

    

    2.4     INVESTMENTS;
      SUBSIDIARIES.
      IQMC
      currently has and has never owned any subsidiary corporation, partnership or
      other business entity and has never made any investments in any other
      corporation, partnership or other business entities. 

    

    2.5     FINANCIAL
      STATEMENTS.
      The IQMC
      Financial Statements attached hereto as Schedule
      2.5
      (the
“IQMC Financial Statements”) were prepared in accordance with United States
      generally accepted accounting principles applied on a consistent basis
      throughout the periods involved, and fairly presents in all Material respects
      the consolidated financial position of IQMC as of the respective dates and
      the
      consolidated results of operations and cash flows for the periods indicated,
      except that the unaudited interim financial statements were or are subject
      to
      normal and recurring year-end adjustments which were not or are not expected
      to
      be Material in amount or effect.

    

    2.6     ABSENCE
      OF UNDISCLOSED LIABILITIES.
      IQMC has
      no liabilities that are reasonably likely to have, individually or in the
      aggregate, a material adverse effect.

    

    2.7     ABSENCE
      OF CERTAIN CHANGES OR EVENTS.
      Since
      December 31, 2004, except as disclosed in the IQMC Financial Statements
      delivered prior to the date of this Agreement there have been no events,
      changes, or occurrences which have had, or are reasonably likely to have,
      individually or in the aggregate, material adverse effect. 

    

    2.8     TAX
      MATTERS. IQMC
      has
      never filed any tax returns.

    

    2.9     INTELLECTUAL
      PROPERTY.
      IQMC
      does not own or use any intellectual property and has never owned or used any
      intellectual property.

     

    2.10     REAL
      PROPERTY.
      IQMC
      does not currently own or lease any real property and has never owned or leased
      any real property.

    

    2.11     COMPLIANCE
      WITH LAWS.
      IQMC
      requires no permits that are not already in existence. IQMC
      is
      not in default under any of the provisions of its Articles of Incorporation
      or
      Bylaws (or other governing instruments).

    

    2.12     LABOR
      RELATIONS.
      IQMC has
      no employees and has never had any employees.

    

    2.13     EMPLOYEE
      BENEFIT PLANS. IQMC
      has
      no employee benefit plans of any kind and has never had any employee benefit
      plans of any kind.

    
      
        
        

      

      
        -3-

        
          

        

      

      
        
        

      

    

    

    2.14     MATERIAL
      CONTRACTS.
      IQMC is
      not a party to any material contract or agreement (oral or written).

    

    2.15     LEGAL
      PROCEEDINGS.
      There is
      no litigation or any other legal or administrative action instituted, pending
      or
      threatened against IQMC or to which IQMC is a party. 

    

    2.16     PINK
      SHEET LISTING.
      The
      IQMC
      Common Stock is currently listed in the “pink sheets”, and IQMC is not aware of
      any reason why the IQMC Common Stock would not qualify for listing on the OTC
      Bulletin Board.

     

    2.17     STATEMENTS
      TRUE AND CORRECT.
      No
      statement, certificate, instrument, or other writing furnished or to be
      furnished by IQMC to OSMOTEX pursuant to this Agreement, contains or will
      contain any untrue statement of material fact or will omit to state a material
      fact necessary to make the statements therein, in light of the circumstances
      under which they were made, not misleading. 

    

    ARTICLE
      3

    

    CERTAIN
      CHANGES AND CONDUCT OF BUSINESS.

    

    3.1     CONSENTS
      AND APPROVALS.
      The
      Parties (i) shall use their best efforts to obtain all necessary consents,
      waivers, authorizations and approvals of all governmental and regulatory
      authorities, domestic and foreign, and of all other Persons, firms or
      corporations required in connection with the execution, delivery and performance
      by them of this Agreement, and (ii) shall diligently assist and cooperate with
      each Party in preparing and filing all documents required to be submitted by
      a
      Party to any governmental or regulatory authority, domestic or foreign, in
      connection with such transactions and in obtaining any governmental consents,
      waivers, authorizations or approvals which may be required to be obtained
      connection with such transactions.

    

    3.2     PUBLIC
      ANNOUNCEMENT.
      Unless
      otherwise required by applicable law, the Parties hereto shall consult with
      each
      other before issuing any press release or otherwise making any public statements
      with respect to this Agreement and shall not issue any such press release or
      make any such public statement prior to such consultation.

    

    ARTICLE
      4

    

    TERMINATION
      AND ABANDONMENT

    

    4.1     METHODS
      OF TERMINATION.
      This
      Agreement may be terminated and the transactions contemplated hereby may be
      abandoned at any time before the Closing:

    

    (a)     By
      the mutual written consent of both Parties; or

    
      
        
        

      

      
        -4-

        
          

        

      

      
        
        

      

    

    

    (b)     By
      either Party if a court of competent jurisdiction or governmental, regulatory
      or
      administrative agency or commission shall have issued an order, decree or ruling
      or taken any other action (which order, decree or ruling the Parties hereto
      shall use its best efforts to lift), which permanently restrains, enjoins or
      otherwise prohibits the transactions contemplated by this
      Agreement.

    

    4.2     SURVIVAL
      OF REPRESENTATIONS AND COVENANTS.
      The
      respective representations, warranties, obligations, covenants, and agreements
      of IQMC shall survive the
      execution of this Agreement for a period of eighteen months.

    

    4.3     ADJUSTMENT
      OF SHARES.
      The
      parties to this Agreement are also parties to a Financing and Listing Agreement
      (the “Financing Agreement”) dated the date hereof. If the share adjustment
      transactions contained in Section 1.3 of the Financing Agreement are not fully
      consummated and completed by the close of business on June 17, 2005, Osmotex
      may, in its sole discretion, terminate and unwind this Agreement in all respects
      without penalties or costs of any kind upon written notice to IQMC. If such
      termination occurs, all of the Shares will revert back to IQMC and IQMC will
      have no rights of any kind relative to Osmotex, including, without limitation,
      any right related to the Licensing Rights.

    

    ARTICLE
      5

    

    POST-CLOSING
      AGREEMENTS

    

    5.1     INDEMNITY.
      Each
      Party shall indemnify and hold the other Party harmless for acts or omissions
      pertaining to this agreement that are not detailed herein and that may occur
      in
      the future without knowledge at the execution of this agreement.

    

    ARTICLE
      6

    

    MISCELLANEOUS
      PROVISIONS

    

    6.1     EXPENSES.
      Each
      Party shall bear and pay all direct costs and expenses incurred by it or on
      its
      behalf in connection with the transactions contemplated hereunder. 

    

    6.1     BROKERS
      AND FINDERS.
      Each
      Party represents and warrants that neither it nor any of its officers,
      directors, employees, or Affiliates has employed any broker or finder or
      incurred any Liability for any financial advisory fees, investment bankers’
fees, brokerage fees, commissions, or finders’ fees in connection with this
      Agreement or the transactions contemplated hereby. 

    

    6.2     ENTIRE
      AGREEMENT.
      This
      Agreement (including the documents and instruments referred to herein, all
      of
      the Recitals stated above, and all schedules and exhibits to this Agreement,
      all
      of which are hereby incorporated by reference into and made a part of this
      Agreement) constitutes the entire agreement between the Parties with respect
      to
      the transactions contemplated hereunder and supersedes all prior arrangements
      or
      understandings with respect thereto, written or oral.

    
      
        
        

      

      
        -5-

        
          

        

      

      
        
        

      

    

    

    6.3     AMENDMENTS. This
      Agreement may only be amended by a subsequent writing signed by all
      Parties.

    

    6.4     WAIVERS.     The
      failure of any Party at any time or times to require performance of any
      provision hereof shall in no manner affect the right of such Party at a later
      time to enforce the same or any other provision of this Agreement. No waiver
      of
      any condition or of the breach of any term contained in this Agreement in one
      or
      more instances shall be deemed to be or construed as a further or continuing
      waiver of such condition or breach or a waiver of any other condition or of
      the
      breach of any other term of this Agreement.

    

    6.5     ASSIGNMENT.
      Neither
      this Agreement nor any of the rights, interests or obligations hereunder shall
      be assigned by any Party hereto (whether by operation of Law or otherwise)
      without the prior written consent of the other Parties. Subject to the preceding
      sentence, this Agreement will be binding upon, inure to the benefit of and
      be
      enforceable by the Parties and their respective successors and
      assigns.

    

    6.6     NOTICES.
      All
      notices, requests, consents and other communications required or permitted
      under
      this Agreement shall be in writing and shall be (as elected by the Person giving
      such notice) hand delivered by messenger or courier service or mailed by
      registered or certified mail (postage prepaid), return receipt requested,
      addressed to:

     

    
      	
              IQMC:
                

            	
              IQ
                MEDICAL CORP.

            
	 	 
	 	 
	
              Copy
                to Counsel: 

            	
               

            
	 	 
	 	 
	
              OSMOTEX:
                

            	
              Osmotex
                A/S

            
	 	 
	 	 
	
              Copy
                to Counsel: 

            	
              Gunster,
                Yoakley & Stewart, P.A.

              500
                East Broward Boulevard, Suite 1400

              Fort
                Lauderdale, Florida 33394

              Attention:
                Robert C. White, Jr., Esq.

            

    

     

    or
      to
      such other address as any Party may designate by notice complying with the
      terms
      of this Section. Each such notice shall be deemed delivered (a) on the date
      delivered, if by messenger or courier service; and (b) either upon the date
      of receipt or refusal of delivery, if mailed.

    

    
      
        
        

      

      
        -6-

        
          

        

      

      
        
        

      

    

    6.7     GOVERNING
      LAW.
      This
      Agreement shall be governed by and construed in accordance with the laws of
      the
      State of Florida, without regard to any applicable conflicts of
      laws.

    

    6.8     JURISDICTION
      AND VENUE.
      The
      Parties acknowledge that a substantial portion of the negotiations and
      anticipated performance of this Agreement occurred or shall occur in Palm Beach
      County, Florida. Any civil action or legal proceeding arising out of or relating
      to this Agreement shall be brought in the courts of record of the State of
      Florida in Palm Beach County or the United States District Court, Southern
      District of Florida. Each Party consents to the jurisdiction of such Florida
      court in any such civil action or legal proceeding and waives any objection
      to
      the laying of venue of any such civil action or legal proceeding in such Florida
      court. Service of any court paper may be effected on such Party by mail, as
      provided in this Agreement, or in such other manner as may be provided under
      applicable laws, rules of procedure or local rules.

    

    6.9     COUNTERPARTS.
      This
      Agreement may be executed in counterparts, which shall be deemed to be an
      original, but all of which together shall constitute one and the same
      instrument.

    

    6.10     CAPTIONS;
      ARTICLES AND SECTIONS.
      The
      captions contained in this Agreement are for reference purposes only and are
      not
      part of this Agreement. Unless otherwise indicated, all references to particular
      Articles or Sections shall mean and refer to the referenced Articles and
      Sections of this Agreement.

    

    6.11     INTERPRETATIONS.
      Neither
      this Agreement nor any uncertainty or ambiguity herein shall be construed or
      resolved against any Party, whether under any rule of construction or otherwise.
      No Party to this Agreement shall be considered the draftsman. The Parties
      acknowledge and agree that this Agreement has been reviewed, negotiated, and
      accepted by all Parties and their attorneys and shall be construed and
      interpreted according to the ordinary meaning of the words used so as fairly
      to
      accomplish the purposes and intentions of all Parties hereto.

    

    6.12     ENFORCEMENT
      OF AGREEMENT.
      The
      Parties hereto agree that irreparable damage would occur in the event that
      any
      of the provisions of this Agreement were not performed in accordance with its
      specific terms or were otherwise breached. It is accordingly agreed that the
      Parties shall be entitled to an injunction or injunctions to prevent breaches
      of
      this Agreement and to enforce specifically the terms and provisions hereof
      in
      any court of the United States or any state having jurisdiction, this being
      in
      addition to any other remedy to which they are entitled at law or in
      equity.

    

    6.13     ENFORCEMENT
      COSTS.
      If any
      civil action, arbitration or other legal proceeding is brought for the
      enforcement of this Agreement, or because of an alleged dispute, breach, default
      or misrepresentation in connection with any provision of this Agreement, the
      successful or prevailing Party or Parties shall be entitled to recover from
      the
      non-prevailing party or parties reasonable attorneys' fees, court costs, sales
      and use taxes and all expenses even if not taxable as court costs (including,
      without limitation, all such fees, taxes, costs and expenses incident to
      arbitration, appellate, bankruptcy and post-judgment proceedings), incurred
      in
      that proceeding, in addition to any other relief to which such Party or Parties
      may be entitled. Attorneys' fees shall include, without limitation, paralegal
      fees, investigative fees, administrative costs, sales and use taxes and all
      other charges billed by the attorney to the prevailing Party (including any
      fees
      and costs associated with collecting such amounts).

    
      
        
        

      

      
        -7-

        
          

        

      

      
        
        

      

    

    

    6.14     SEVERABILITY.
      Any term
      or provision of this Agreement which is invalid or unenforceable in any
      jurisdiction shall, as to that jurisdiction, be ineffective to the extent of
      such invalidity or unenforceability without rendering invalid or unenforceable
      the remaining terms and provisions of this Agreement or affecting the validity
      or enforceability of any of the terms or provisions of this Agreement in any
      other jurisdiction. If any provision of this Agreement is so broad as to be
      unenforceable, the provision shall be interpreted to be only so broad as is
      enforceable.

    

    IN
      WITNESS WHEREOF,
      the
      Parties hereto have executed this Capital Contribution Agreement as of the
      date
      first above written.

     

    
      
        	 	 	 
	 	IQ
                MEDICAL
                CORP.
	 
 	 
 	 
 
	 	By:  	/s/ Shannon
                Daigle
	 	
                
                  
Name:
                  Shannon Daigle

              
	 	Its:
                President

      

      
        	 	 	 
	 	OSMOTEX
                USA, INC.
	 
 	 
 	 
 
	 	By:  	/s/ Robert
                Rudman
	 	
                
Name:
                Robert Rudman
	 	Its:
                President

      

    
      
        
        

      

        -8-EXHIBIT
      10.3

     

    FINANCING
      AND LISTING AGREEMENT

    

    THIS
      FINANCING AND LISTING AGREEMENT (the
      “Agreement”) is made and entered into on June 9, 2005 by and among IQ
      MEDICAL CORP.,
      a
      Colorado corporation (“IQMC”), OSMOTEX
      USA, INC., a
      Florida
      corporation (“Osmotex”), and D.P.
      MARTIN & ASSOCIATES, INC.,
      a
      Florida corporation (the “Finder”).

    

    RECITALS:

    

    WHEREAS,
      on
      the
      date of this Agreement, Osmotex will enter into a transaction (the “Capital
      Contribution Transaction”) with IQMC pursuant to which Osmotex will contribute
      certain technology license rights to the capital of IQMC in exchange for shares
      of IQMC common stock (“IQMC Common Stock”);

    

    WHEREAS,
      IQMC’s
      common stock is currently traded on the “pink sheets”; 

    

    WHEREAS,
      the
      listing of IQMC’s common stock on the OTC Bulletin Board (the “OTC Bulletin
      Board”) after the consummation of the Capital Contribution Transaction is a
      critical component of Osmotex’s decision to consummate the Capital Contribution
      Transaction;

    

    WHEREAS,
      the
      Finder has committed to locate and obtain financing for IQMC after the
      consummation of the Capital Contribution Transaction and to use its best efforts
      to effect the listing of the IQMC Common Stock on the OTC Bulletin
      Board;

    

    WHEREAS,
      Osmotex
      believes that IQMC will need to obtain significant external financing in the
      short term, and accordingly the Finder’s commitment to obtain financing for IQMC
      as discussed in this Agreement is a critical component of Osmotex’s decision to
      consummate the Capital Contribution Transaction; and

    

    WHEREAS,
      the
      parties to this Agreement wish to document their agreement regarding these
      matters in this Agreement.

    

    NOW,
      THEREFORE,
      in
      consideration of the mutual terms, conditions and other agreements set forth
      herein, and for other valuable consideration, the receipt and adequacy of which
      are hereby conclusively acknowledged, the Parties hereto, intending to be
      legally bound, hereby agree as follows:

    

    ARTICLE
      1

    

    FINANCING
      COMMITMENT; SHARE ADJUSTMENTS

    

    1.1     FINANCING
      COMMITMENT; ESCROW.
      The
      Finder covenants and agrees that it will locate at least of total of $500,000
      in
      external financing (the “Financing Amount”) for IQMC and that this total
      Financing Amount will be received by or made available (without restrictions
      on
      such availability) to IQMC on or before December 31, 2005. To secure this
      financing commitment, the Finder will cause 1,000,000 shares of IQMC Common
      Stock owned or controlled by them to be placed in escrow with an escrow agent
      agree to by both parties (the “Escrow Agent”). 

    

    
      
        
        

      

      
        -1-

        
          

        

      

      
        
        

      

    

    1.2     FAILURE
      TO DELIVER FINANCING.
      If
      the
      total Financing Amount is not received by or made available (without
      restrictions on such availability) to IQMC on or before December 31, 2005 on
      terms and conditions that are acceptable to IQMC in its sole discretion, the
      Escrow Agent shall deliver to IQMC the number of shares of IQMC Common Stock
      (the “Relinquished Shares”) equal to (a) the amount by which any external
      financing received by or made available (without any restrictions on such
      availability) to IQMC (through the efforts of the Finder) on or before December
      31, 2005 is less than $500,000, divided by (b) the Share Price (as defined
      herein). “Share Price” shall mean the price of one share of IQMC Common Stock,
      which shall be equal to the average price of the IQMC Common Stock using the
      most recent price quotation or “asked” price (as applicable) for the IQMC Common
      Stock as of the Valuation Date (as defined herein) if the IQMC Common Stock
      is
      quoted on any stock exchange or electronic stock trading system. If the IQMC
      Common Stock is quoted on any stock exchange or electronic stock trading system
      at that time, the Share Price shall be determined by dividing the value of
      IQMC
      (as determined by a written valuation report prepared by IQMC’s then regularly
      retained accounting firm) by the total number of shares of IQMC Common Stock
      outstanding as of the Valuation Date (as defined herein). “Valuation Date” shall
      mean December 31, 2005 or, if a price is not available on that date, the price
      on the next subsequent day for which a price is available. The Finder covenants
      and agrees that (x) it will relinquish to IQMC all ownership in and all rights
      of any kind, including voting and economic rights, in all Relinquished Shares,
      (and (y) it will perform all actions and execute all documents required or
      desired by IQMC to effect the transactions contemplated by this Article 1.
      If
      the Finder does not directly own shares of IQMC Common Stock, they will take
      all
      steps necessary to require other parties to relinquish ownership of IQMC Common
      Stock so that the intent of this Article 1 is satisfied.
      The Finder shall pay all expenses incurred by the accounting firm referred
      to in
      this Section 1.2.

    

    1.3     Required
      Share Adjustments.
      The
      Finder covenants and agrees that it will cause the shareholders of IQMC (other
      than Osmotex) to take all steps necessary and execute all documentation required
      by Osmotex to relinquish ownership of a total of 31,330,877 shares of IQMC
      Common Stock on or before June 17, 2005. These steps and documentation must
      be
      acceptable to Osmotex in its sole discretion. The Finder acknowledges, agrees
      and covenants that it is the intent of the parties to this Agreement that
      Osmotex will own a total of 85.0% of the outstanding IQMC Common Stock (on
      a
      fully diluted basis) after the transactions contemplated in this Section 1.3
      are
      consummated. If the transactions contemplated in this Section 1.3 are not
      consummated on or before June 17, 2005, Osmotex may, in its sole discretion
      and
      without penalties or costs of any kind, terminate this Agreement and the Capital
      Contribution Agreement between Osmotex and IQMC upon written notice to IQMC
      and
      the Finder.

    

    
      
        
        

      

      
        -2-

        
          

        

      

      
        
        

      

    

    ARTICLE
      2

    

    LISTING
      REQUIREMENTS

    

    2.1     Listing
      of IQMC Common Stock on OTC Bulletin Board.
      The
      Finder covenants and agrees that it will use its best efforts to cause IQMC’s
      Common Stock to be listed for trading on the OTC Bulletin Board prior to
      December 31, 2005. If IQMC’s Common Stock is not listed for trading on the OTC
      Bulletin Board prior to December 31, 2005 for any reason, however, the Finder
      will take all steps necessary to identify a new corporate entity (acceptable
      to
      IQMC in its sole discretion) with which IQMC can enter into a merger, share
      exchange, stock purchase or other similar transaction and which is a suitable
      vehicle for allowing IQMC to achieve the listing of the IQMC Common Stock on
      the
      OTC Bulletin Board. The Finder will use its best efforts to locate and identify
      this new corporate entity as quickly as possible, but in no event shall the
      new
      corporate entity be proposed to IQMC later than January 31, 2006. The Finder
      will pay all of IQMC’s reasonable fees and expenses associated with this
      transaction, including, without limitation, legal and accounting
      fees.

    

    ARTICLE
      3

    

    GENERAL
      PROVISIONS

    

    2.1     EXPENSES.
      Except
      as specifically provided in this Agreement, each party shall bear and pay all
      costs and expenses incurred by it or on its behalf in connection with the
      transactions contemplated hereunder.

    

    2.2     ENTIRE
      AGREEMENT.
      This
      Agreement (including the documents and instruments referred to herein, all
      of
      the Recitals stated above, and all schedules and exhibits to this Agreement,
      all
      of which are hereby incorporated by reference into and made a part of this
      Agreement) constitutes the entire agreement between the Parties with respect
      to
      the transactions contemplated hereunder and supersedes all prior arrangements
      or
      understandings with respect thereto, written or oral.

    

    2.3     AMENDMENTS. This
      Agreement may only be amended by a subsequent writing signed by all
      parties.

    

    2.4     WAIVERS. The
      failure of any party at any time or times to require performance of any
      provision hereof shall in no manner affect the right of such party at a later
      time to enforce the same or any other provision of this Agreement. No waiver
      of
      any condition or of the breach of any term contained in this Agreement in one
      or
      more instances shall be deemed to be or construed as a further or continuing
      waiver of such condition or breach or a waiver of any other condition or of
      the
      breach of any other term of this Agreement.

    

    2.5     ASSIGNMENT.
      Neither
      this Agreement nor any of the rights, interests or obligations hereunder shall
      be assigned by any Party hereto (whether by operation of Law or otherwise)
      without the prior written consent of the other Parties. Subject to the preceding
      sentence, this Agreement will be binding upon, inure to the benefit of and
      be
      enforceable by the Parties and their respective successors and
      assigns.

    
      
        
        

      

      
        -3-

        
          

        

      

      
        
        

      

    

    

    2.6     NOTICES.
      All
      notices, requests, consents and other communications required or permitted
      under
      this Agreement shall be in writing and shall be (as elected by the Person giving
      such notice) hand delivered by messenger or courier service or mailed by
      registered or certified mail (postage prepaid), return receipt requested,
      addressed to:

     

    
      	
              IQMC:
                

            	
              IQ
                MEDICAL CORP.

            
	 	 
	 	 
	
              Copy
                to Counsel: 

            	 
	 	 
	 	 
	
              OSMOTEX:
                

            	
              Osmotex
                USA, Inc.

            
	 	 
	 	 
	
              Copy
                to Counsel: 

            	
              Gunster,
                Yoakley & Stewart, P.A.

              500
                East Broward Boulevard, Suite 1400

              Fort
                Lauderdale, Florida 33394

              Facsimile
                Number: (954) 888-2037

              Attention:
                Robert C. White, Jr.,
                Esq.     

            
	 	 
	 	 
	
              The
                Finder:

            	
              D.P.
                Martin & Associates

              500
                Australian Avenue, Suite 700

              West
                Palm Beach, FL 33401

              561/651-4146

            

    

    

    

    or
      to
      such other address as any party may designate by notice complying with the
      terms
      of this Section. Each such notice shall be deemed delivered (a) on the date
      delivered, if by messenger or courier service; and (b) either upon the date
      of receipt or refusal of delivery, if mailed.

    

    2.7     GOVERNING
      LAW.
      This
      Agreement shall be governed by and construed in accordance with the laws of
      the
      State of Florida, without regard to any applicable conflicts of
      laws.

    

    2.8     JURISDICTION
      AND VENUE.
      The
      Parties acknowledge that a substantial portion of the negotiations and
      anticipated performance of this Agreement occurred or shall occur in Palm Beach
      County, Florida. Any civil action or legal proceeding arising out of or relating
      to this Agreement shall be brought in the courts of record of the State of
      Florida in Palm Beach County or the United States District Court, Southern
      District of Florida. Each party consents to the jurisdiction of such Florida
      court in any such civil action or legal proceeding and waives any objection
      to
      the laying of venue of any such civil action or legal proceeding in such Florida
      court. Service of any court paper may be effected on such Party by mail, as
      provided in this Agreement, or in such other manner as may be provided under
      applicable laws, rules of procedure or local rules.

    
      
        
        

      

      
        -4-

        
          

        

      

      
        
        

      

    

    

    2.9     COUNTERPARTS.
      This
      Agreement may be executed in counterparts, which shall be deemed to be an
      original, but all of which together shall constitute one and the same
      instrument.

    

    2.10     CAPTIONS;
      ARTICLES AND SECTIONS.
      The
      captions contained in this Agreement are for reference purposes only and are
      not
      part of this Agreement. Unless otherwise indicated, all references to particular
      Articles or Sections shall mean and refer to the referenced Articles and
      Sections of this Agreement.

    

    2.11     INTERPRETATIONS.
      Neither
      this Agreement nor any uncertainty or ambiguity herein shall be construed or
      resolved against any Party, whether under any rule of construction or otherwise.
      No party to this Agreement shall be considered the draftsman. The Parties
      acknowledge and agree that this Agreement has been reviewed, negotiated, and
      accepted by all parties and their attorneys and shall be construed and
      interpreted according to the ordinary meaning of the words used so as fairly
      to
      accomplish the purposes and intentions of all Parties hereto.

    

    2.12     ENFORCEMENT
      OF AGREEMENT.
      The
      Parties hereto agree that irreparable damage would occur in the event that
      any
      of the provisions of this Agreement were not performed in accordance with its
      specific terms or were otherwise breached. It is accordingly agreed that the
      parties shall be entitled to an injunction or injunctions to prevent breaches
      of
      this Agreement and to enforce specifically the terms and provisions hereof
      in
      any court of the United States or any state having jurisdiction, this being
      in
      addition to any other remedy to which they are entitled at law or in
      equity.

    

    2.13     ENFORCEMENT
      COSTS.
      If any
      civil action, arbitration or other legal proceeding is brought for the
      enforcement of this Agreement, or because of an alleged dispute, breach, default
      or misrepresentation in connection with any provision of this Agreement, the
      successful or prevailing party or parties shall be entitled to recover from
      the
      non-prevailing party or parties reasonable attorneys' fees, court costs, sales
      and use taxes and all expenses even if not taxable as court costs (including,
      without limitation, all such fees, taxes, costs and expenses incident to
      arbitration, appellate, bankruptcy and post-judgment proceedings), incurred
      in
      that proceeding, in addition to any other relief to which such party or parties
      may be entitled. Attorneys' fees shall include, without limitation, paralegal
      fees, investigative fees, administrative costs, sales and use Taxes and all
      other charges billed by the attorney to the prevailing party (including any
      fees
      and costs associated with collecting such amounts).

    
      
        
        

      

      
        -5-

        
          

        

      

      
        
        

      

    

    

    2.14     SEVERABILITY.
      Any term
      or provision of this Agreement which is invalid or unenforceable in any
      jurisdiction shall, as to that jurisdiction, be ineffective to the extent of
      such invalidity or unenforceability without rendering invalid or unenforceable
      the remaining terms and provisions of this Agreement or affecting the validity
      or enforceability of any of the terms or provisions of this Agreement in any
      other jurisdiction. If any provision of this Agreement is so broad as to be
      unenforceable, the provision shall be interpreted to be only so broad as is
      enforceable.

    

    IN
      WITNESS WHEREOF,
      the
      parties hereto have executed this Financing and Listing Agreement as of the
      date
      first above written.

     

    
      
        	 	 	 
	 	IQ
                MEDICAL
                CORP.
	 
 	 
 	 
 
	 	By:  	/s/ Shannon
                Daigle
	 	
                
Name:
                Shannon Daigle
	 	Its: President

      

      
        	 	 	 
	 	OSMOTEX
                USA, INC.
	 
 	 
 	 
 
	 	By:  	/s/ Robert
                Rudman
	 	
                
Name:
                Robert Rudman
	 	Its:
                President

      

    

                             

    
      	 	 	 
	 	D.P.
              MARTIN & ASSOCIATES, INC.
	 
 	 
 	 
 
	 	By:  	/s/ Douglas
              P. Martin
	 	
              
Name:
              Douglas P. Martin
	 	Its:
              President

    

    

     

    
      
        
        

      

        -6-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00097-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00097-of-00352.parquet"}]]